Cargando…

Comments on the Risk of Gout in Patients with Psoriasis [Letter]

Detalles Bibliográficos
Autores principales:	Yeh, Wen-Bin, Lee, Wei-Kai, Chou, Mei-Chia, Jou, I-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297038/ https://www.ncbi.nlm.nih.gov/pubmed/35874906 http://dx.doi.org/10.2147/CLEP.S379488

Ejemplares similares

The Risk of Gout in Patients with Psoriasis: A Population-Based Cohort Study in Taiwan
por: Wei, James Cheng-Chung, et al.
Publicado: (2022)

Chronic tophaceous gout in patients with psoriasis
por: Lobato, Laís Cruz, et al.
Publicado: (2017)

Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
por: Huang, Jin-Xian, et al.
Publicado: (2023)

Comment on Letter to the Editor
por: Dettori, Joseph R., et al.
Publicado: (2020)

Comment: Prevalence of Hypercholesterolemia and Awareness of Risk Factors, Prevention and Management Among Adults [Letter]
por: Nugroho, Heru Santoso Wahito, et al.
Publicado: (2023)

Comments on the Article by Arnljots and Economou [Letter]
por: Paletta Guedes, Ricardo Augusto
Publicado: (2021)

Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2017)

Authors’ Reply to Huang and Zhang: Comment on “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”
por: Tong, Qiang, et al.
Publicado: (2023)

Gout Augments the Risk of Cardiovascular Disease in Patients With Psoriasis: A Population-Based Cohort Study
por: Chen, Zhiyong, et al.
Publicado: (2021)

Comment/response to letter to editor
por: Ayoub, Elias
Publicado: (2021)

Sarcoidosis, Psoriasis, and Gout: Syndrome or Coincidence?
por: Kaplan, Herbert, et al.
Publicado: (1960)

Comment on “occupational psoriasis after exposure to rockwool”
por: Koch, Christoph, et al.
Publicado: (2021)

Comment on “Metabolic Changes and Serum Ghrelin Level in Patients with Psoriasis”
por: Agilli, Mehmet, et al.
Publicado: (2015)

Comment on Helicobacter pylori seroprevalence and the occurrence and severity of psoriasis - Reply
por: Mesquita, Priscila Miranda Diogo, et al.
Publicado: (2017)

Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Letter]
por: Ghanghro, Laraib
Publicado: (2021)

Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021)

Comments on – Experiences of Obese Polish Patients When Interacting with Healthcare Professionals [Letter]
por: Ikotun, Oluwaseun, et al.
Publicado: (2020)

Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis
por: Deng, Jian‐Hao, et al.
Publicado: (2022)

EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
por: Scadding, Glenis K, et al.
Publicado: (2023)

Letters on the Cause and Treatment of the Gout, &c.
Publicado: (1810)

Comments on “Validity and Reliability of the Flourishing Scale in a Sample of Older Adults in Iran” [Letter]
por: Priastana, I Ketut Andika
Publicado: (2020)

Gout with Hearing Loss
por: Huang, Wenhan, et al.
Publicado: (2021)

Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
por: van Leeuwen, Kevin D. B., et al.
Publicado: (2019)

Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]
por: Houlind, Morten Baltzer, et al.
Publicado: (2022)

Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
por: Rastmanesh, Reza
Publicado: (2021)

Comment to the Letter to the Editor entitled “Lithium in drinking water and suicide risk” by Tomoyuki Kawada
por: Luca, Antonina, et al.
Publicado: (2022)

Higher IL-9 Level Is Associated with Psoriasis Vulgaris Complicated by Metabolic Syndrome [Letter]
por: Yalcinkaya, Ali, et al.
Publicado: (2023)

Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis: Letter to the Editor
por: Gooderham, M., et al.
Publicado: (2019)

Response to letter: Comments on “Hyaluronidase: an overview of its properties, applications, and side effects”
por: Jung, Hyunwook
Publicado: (2020)

Oral Processing, Satiation and Obesity: Overview and Hypotheses: A Short Comment [Letter]
por: Rastmanesh, Reza
Publicado: (2021)

Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
por: Barsouk, Adam, et al.
Publicado: (2021)

Letter to the Editor
por: Reddy, Prabashni, et al.
Publicado: (2013)

Comments on ‘French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults’
por: Schuster, C., et al.
Publicado: (2019)

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Gout in the peri-scapular region manifests as paradoxical low back pain
por: Wang, Gang, et al.
Publicado: (2023)

Letter to the Editor Regarding Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis
por: Pettitt, Dan, et al.
Publicado: (2022)

Effects of colchicine use on ischemic and hemorrhagic stroke risk in diabetic patients with and without gout
por: Yeh, Jun-Jun, et al.
Publicado: (2022)

Effect of cylinder power and axis changes on vision in astigmatic participants: a comment [Letter]
por: Remón, Laura, et al.
Publicado: (2019)

Response to letter to editor: ‘Comment on Arch et al., Trials. 2016;17:517’
por: Arch, B. N., et al.
Publicado: (2017)

Comments on: An Undergraduate Surgery Interest Group: Introducing Premedical Students to the Practice of Surgery [Letter]
por: Chakhachiro, Adham
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_muvbmmsp67hvkdjbe23s0b7r06